# Latanoprost Versus Fotil

> **NCT00304785** · PHASE4 · COMPLETED · sponsor: **Pharmaceutical Research Network** · enrollment: 36 (estimated)

## Conditions studied

- Open-Angle Glaucoma
- Ocular Hypertension

## Interventions

- **DRUG:** latanoprost 0.005%
- **DRUG:** Fotil
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00304785
- **Lead sponsor:** Pharmaceutical Research Network
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-05
- **Primary completion:** —
- **Final completion:** 2007-10
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2007-10-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00304785

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00304785, "Latanoprost Versus Fotil". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00304785. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*